Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection

Byung Il Yeh, Kwang Hyub Han, Hyean Woo Lee, Joon Hyung Sohn, Wang Shick Ryu, Do Jun Yoon, Joonho Yoon, Hyun Won Kim, In Deok Kong, Sei Jin Chang, Jong Whan Choi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Interferon-α (IFN-α) has been used to treat hepatitis C Virus (HCV)-induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN-α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the beginning of IFN-α therapy, and the sequences of the interferon sensitivity determining region (ISDR). However, there have also been reports showing that these have no relation to an IFN-α effect. In a previous study, it was found that the nucleotide sequence variation in the hypervariable region (HVR) 1 of the HCV could predict the effect of IFN-α. In the present investigation, an attempt was made to determine the predictive factors of IFN-α therapy. Twenty-six patients with HCV infection were treated with IFN-α. Among these, 13 patients recovered after 3 to 6 months of IFN-α treatment, although the other 13 patients showed no response after 6 months of treatment with IFN-α. In order to determine the predictive factors of IFN-α therapy, the ALT levels, HCV genotypes, HCV serum titer, and the quasispecies of HVR 1 were compared between responders and non-responders. It is suggested that the variation in the HVR 1 and HCV serum titer can be used to predict the effect of IFN-α.

Original languageEnglish
Pages (from-to)481-487
Number of pages7
JournalJournal of Medical Virology
Volume66
Issue number4
DOIs
Publication statusPublished - 2002 Mar 19

Fingerprint

Virus Diseases
Hepacivirus
Interferons
Therapeutics
Viral Load
Genotype
Serum
RNA

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Yeh, Byung Il ; Han, Kwang Hyub ; Lee, Hyean Woo ; Sohn, Joon Hyung ; Ryu, Wang Shick ; Yoon, Do Jun ; Yoon, Joonho ; Kim, Hyun Won ; Kong, In Deok ; Chang, Sei Jin ; Choi, Jong Whan. / Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection. In: Journal of Medical Virology. 2002 ; Vol. 66, No. 4. pp. 481-487.
@article{eb152766b8a44c2dac91fa79a183c339,
title = "Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection",
abstract = "Interferon-α (IFN-α) has been used to treat hepatitis C Virus (HCV)-induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN-α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the beginning of IFN-α therapy, and the sequences of the interferon sensitivity determining region (ISDR). However, there have also been reports showing that these have no relation to an IFN-α effect. In a previous study, it was found that the nucleotide sequence variation in the hypervariable region (HVR) 1 of the HCV could predict the effect of IFN-α. In the present investigation, an attempt was made to determine the predictive factors of IFN-α therapy. Twenty-six patients with HCV infection were treated with IFN-α. Among these, 13 patients recovered after 3 to 6 months of IFN-α treatment, although the other 13 patients showed no response after 6 months of treatment with IFN-α. In order to determine the predictive factors of IFN-α therapy, the ALT levels, HCV genotypes, HCV serum titer, and the quasispecies of HVR 1 were compared between responders and non-responders. It is suggested that the variation in the HVR 1 and HCV serum titer can be used to predict the effect of IFN-α.",
author = "Yeh, {Byung Il} and Han, {Kwang Hyub} and Lee, {Hyean Woo} and Sohn, {Joon Hyung} and Ryu, {Wang Shick} and Yoon, {Do Jun} and Joonho Yoon and Kim, {Hyun Won} and Kong, {In Deok} and Chang, {Sei Jin} and Choi, {Jong Whan}",
year = "2002",
month = "3",
day = "19",
doi = "10.1002/jmv.2169",
language = "English",
volume = "66",
pages = "481--487",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection. / Yeh, Byung Il; Han, Kwang Hyub; Lee, Hyean Woo; Sohn, Joon Hyung; Ryu, Wang Shick; Yoon, Do Jun; Yoon, Joonho; Kim, Hyun Won; Kong, In Deok; Chang, Sei Jin; Choi, Jong Whan.

In: Journal of Medical Virology, Vol. 66, No. 4, 19.03.2002, p. 481-487.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection

AU - Yeh, Byung Il

AU - Han, Kwang Hyub

AU - Lee, Hyean Woo

AU - Sohn, Joon Hyung

AU - Ryu, Wang Shick

AU - Yoon, Do Jun

AU - Yoon, Joonho

AU - Kim, Hyun Won

AU - Kong, In Deok

AU - Chang, Sei Jin

AU - Choi, Jong Whan

PY - 2002/3/19

Y1 - 2002/3/19

N2 - Interferon-α (IFN-α) has been used to treat hepatitis C Virus (HCV)-induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN-α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the beginning of IFN-α therapy, and the sequences of the interferon sensitivity determining region (ISDR). However, there have also been reports showing that these have no relation to an IFN-α effect. In a previous study, it was found that the nucleotide sequence variation in the hypervariable region (HVR) 1 of the HCV could predict the effect of IFN-α. In the present investigation, an attempt was made to determine the predictive factors of IFN-α therapy. Twenty-six patients with HCV infection were treated with IFN-α. Among these, 13 patients recovered after 3 to 6 months of IFN-α treatment, although the other 13 patients showed no response after 6 months of treatment with IFN-α. In order to determine the predictive factors of IFN-α therapy, the ALT levels, HCV genotypes, HCV serum titer, and the quasispecies of HVR 1 were compared between responders and non-responders. It is suggested that the variation in the HVR 1 and HCV serum titer can be used to predict the effect of IFN-α.

AB - Interferon-α (IFN-α) has been used to treat hepatitis C Virus (HCV)-induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN-α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the beginning of IFN-α therapy, and the sequences of the interferon sensitivity determining region (ISDR). However, there have also been reports showing that these have no relation to an IFN-α effect. In a previous study, it was found that the nucleotide sequence variation in the hypervariable region (HVR) 1 of the HCV could predict the effect of IFN-α. In the present investigation, an attempt was made to determine the predictive factors of IFN-α therapy. Twenty-six patients with HCV infection were treated with IFN-α. Among these, 13 patients recovered after 3 to 6 months of IFN-α treatment, although the other 13 patients showed no response after 6 months of treatment with IFN-α. In order to determine the predictive factors of IFN-α therapy, the ALT levels, HCV genotypes, HCV serum titer, and the quasispecies of HVR 1 were compared between responders and non-responders. It is suggested that the variation in the HVR 1 and HCV serum titer can be used to predict the effect of IFN-α.

UR - http://www.scopus.com/inward/record.url?scp=0036198187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036198187&partnerID=8YFLogxK

U2 - 10.1002/jmv.2169

DO - 10.1002/jmv.2169

M3 - Article

C2 - 11857525

AN - SCOPUS:0036198187

VL - 66

SP - 481

EP - 487

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 4

ER -